GlassScriptPhysician profile
John Steven Parker
NPI 1114033016
$19,328.93
in general payments reported to CMS, 2019-2025
31 companies · $1,031 in 2025
The $1,031 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,528 · 2020: $715 · 2021: $1,771 · 2022: $2,967 · 2023: $5,377 · 2024: $938 · 2025: $1,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,847 · Consulting Fee: $2,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,846.50 |
| Consulting Fee | $2,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $8,960.27 | 2020-2025 | Kxl System (Not Refurbished), Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Photrexa Viscous and Photrexa |
| Avedro INC. | $6,250.00 | 2019 | |
| Eyevance Pharmaceuticals LLC | $673.76 | 2020-2022 | |
| Alcon Vision LLC | $627.55 | 2019-2025 | Clareon, Tryptyr |
| Allergan, INC. | $468.28 | 2020-2022 | |
| Carl Zeiss Meditec USA, INC. | $426.08 | 2022-2025 | Lumera 700 |
| Mallinckrodt Hospital Products INC. | $265.60 | 2020-2024 | Acthar |
| Dompe US, INC. | $176.33 | 2019-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $154.98 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $153.80 | 2022-2025 | Envista Mx60 Iol, Scoutpro Osmolarity System, Vyzulta |
| Aerie Pharmaceuticals, INC. | $152.04 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $148.68 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $132.82 | 2019-2022 | |
| Iridex Corporation | $115.00 | 2022 | |
| Carl Zeiss Meditec, INC. | $96.96 | 2020-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $58.74 | 2023 | Exparel |
| Sight Sciences, INC. | $49.59 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Oyster Point Pharma, INC. | $44.99 | 2022-2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $42.30 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $38.23 | 2021 | |
| Ocular Therapeutix, INC. | $34.88 | 2019 | |
| Abbvie INC. | $34.00 | 2022 | |
| Rxsight INC | $32.33 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Ani Pharmaceuticals, INC. | $31.37 | 2025 | Purified Cortrophin Gel |
| Harrow Eye, LLC | $30.37 | 2025 | Vevye |
| New World Medical,INC. | $24.12 | 2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Kedrion Biopharma, INC. | $23.46 | 2025 | Gammaked, Koate, Kedrab |
| Novartis Pharmaceuticals Corporation | $22.40 | 2019 | |
| Biotissue Holdings INC. | $21.94 | 2022 | |
| Mallinckrodt Enterprises LLC | $19.25 | 2019 | |
| Shire North American Group INC | $18.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.